X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Glenmark Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs GLENMARK PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS GLENMARK PHARMA J.B.CHEMICALS/
GLENMARK PHARMA
 
P/E (TTM) x 14.0 14.0 99.7% View Chart
P/BV x 2.2 3.9 56.3% View Chart
Dividend Yield % 0.2 0.3 54.2%  

Financials

 J.B.CHEMICALS   GLENMARK PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
GLENMARK PHARMA
Mar-16
J.B.CHEMICALS/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs3181,262 25.2%   
Low Rs200672 29.7%   
Sales per share (Unadj.) Rs148.0270.6 54.7%  
Earnings per share (Unadj.) Rs19.124.9 76.7%  
Cash flow per share (Unadj.) Rs23.934.4 69.6%  
Dividends per share (Unadj.) Rs0.502.00 25.0%  
Dividend yield (eoy) %0.20.2 93.4%  
Book value per share (Unadj.) Rs128.9151.3 85.2%  
Shares outstanding (eoy) m84.82282.16 30.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.73.6 48.9%   
Avg P/E ratio x13.638.9 34.9%  
P/CF ratio (eoy) x10.828.1 38.5%  
Price / Book Value ratio x2.06.4 31.4%  
Dividend payout %2.68.0 32.6%   
Avg Mkt Cap Rs m21,951272,778 8.0%   
No. of employees `0002.710.0 27.3%   
Total wages/salary Rs m1,84113,782 13.4%   
Avg. sales/employee Rs Th4,590.97,614.9 60.3%   
Avg. wages/employee Rs Th673.41,374.8 49.0%   
Avg. net profit/employee Rs Th592.1700.2 84.6%   
INCOME DATA
Net Sales Rs m12,55176,340 16.4%  
Other income Rs m542356 152.0%   
Total revenues Rs m13,09376,696 17.1%   
Gross profit Rs m2,05514,172 14.5%  
Depreciation Rs m4122,691 15.3%   
Interest Rs m961,789 5.3%   
Profit before tax Rs m2,08810,048 20.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m4693,028 15.5%   
Profit after tax Rs m1,6197,019 23.1%  
Gross profit margin %16.418.6 88.2%  
Effective tax rate %22.530.1 74.5%   
Net profit margin %12.99.2 140.3%  
BALANCE SHEET DATA
Current assets Rs m7,77859,096 13.2%   
Current liabilities Rs m4,35840,018 10.9%   
Net working cap to sales %27.225.0 109.0%  
Current ratio x1.81.5 120.9%  
Inventory Days Days5575 72.9%  
Debtors Days Days80119 67.1%  
Net fixed assets Rs m5,71339,075 14.6%   
Share capital Rs m170282 60.1%   
"Free" reserves Rs m10,54730,281 34.8%   
Net worth Rs m10,93742,703 25.6%   
Long term debt Rs m024,873 0.0%   
Total assets Rs m15,574111,026 14.0%  
Interest coverage x22.86.6 344.9%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.7 117.2%   
Return on assets %11.07.9 138.8%  
Return on equity %14.816.4 90.0%  
Return on capital %20.017.5 114.0%  
Exports to sales %48.743.3 112.6%   
Imports to sales %7.17.4 95.3%   
Exports (fob) Rs m6,11533,044 18.5%   
Imports (cif) Rs m8895,672 15.7%   
Fx inflow Rs m6,16936,945 16.7%   
Fx outflow Rs m1,28561,066 2.1%   
Net fx Rs m4,884-24,122 -20.2%   
CASH FLOW
From Operations Rs m1,3973,449 40.5%  
From Investments Rs m-320-8,802 3.6%  
From Financial Activity Rs m-1,1966,986 -17.1%  
Net Cashflow Rs m-102934 -11.0%  

Share Holding

Indian Promoters % 55.4 48.3 114.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 6.9 49.1%  
FIIs % 3.9 34.4 11.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 10.5 352.4%  
Shareholders   30,437 56,727 53.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ALKEM LABORATORIES  FRESENIUS KABI ONCO.  FDC LTD.  ASTRAZENECA PHARMA  STRIDES SHASUN LTD  

Compare J.B.CHEMICALS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Lupin up 4%(01:30 pm)

After opening the day flat, share markets in India remained rangebound and are presently trading marginally above the dotted line.

Related Views on News

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Glenmark: High Costs hit the Bottom line (Quarterly Results Update - Detailed)

Nov 8, 2016

Glenmark has announced its 2QFY16 results. The company has reported 15.7% YoY growth in net sales and 3.5% YoY increase in net profits. Here is our analysis of the results.

Glenmark: Other Income Boosts Profit Growth (Quarterly Results Update - Detailed)

Sep 6, 2016

Glenmark has announced its 1QFY17 results. The company has reported 15.8% YoY growth in net sales and 24% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 24, 2017 01:56 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - MERCK LTD COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS